drugset / Trial / NCT00391898
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
RandomizedParallel-groupDouble-blindTreatment
Summary
The study evaluated the efficacy of levodopa/carbidopa/entacapone vs levodopa/carbidopa in patients with Parkinson's disease and early wearing-off with levodopa
Timeline
- Start
- 2006-10
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entacapone | Small molecule | 200 mg | Oral |
| Background | Carbidopa | Unknown | 25 mg | Oral |
| Background | Carbidopa | Unknown | 37.5 mg | Oral |
| Background | Levodopa | Small molecule | 100 mg | Oral |
| Background | Levodopa | Small molecule | 150 mg | Oral |